Global Anatomic Pathology Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 21.30 Billion |
 Market Size (Forecast Year) |
USD 36.20 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Anatomic Pathology Market Segmentation, By Product & Service (Instrument, Consumables, Antibodies, Others), End User (Pathology Labs, Research Institutes, Hospitals, Others), Application (Disease Diagnosis, Drug Discovery & Development, Other Applications) – Industry Trends and Forecast to 2031.
Anatomic Pathology Market Analysis
Digital pathology has enabled pathologists to work remotely, increasing their overall productivity and assisting them in addressing case backlogs. Over the last few years, the adoption of these technologies has increased. Increased clinical use of biomarkers allows pathologists to determine disease pathogenesis at the molecular level and further guides clinical decision-making, improving patient outcomes.
Anatomic Pathology Market Size
Global anatomic pathology market size was valued at USD 21.30 billion in 2023 and is projected to reach USD 36.20 billion by 2031, with a CAGR of 6.85% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Anatomic Pathology Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Allergan (Ireland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Abbott (U.S.) |
|
Market Opportunities |
|
Anatomic Pathology Market Definition
Anatomic pathology is a medical specialty that requires the microscopic, macroscopic, biochemical, immunologic, and molecular examination of organs and tissues in order to diagnose disease. Surgical pathology has evolved dramatically in recent years, from an ancient examination of whole bodies (autopsy) to modern techniques required for cancer diagnosis and prognosis to guide treatment decision-making in oncology.
Anatomic Pathology Market Dynamics
Drivers
- The rise in the cases of cancer
Cancer is the world's second leading cause of death, accounting for 10 million deaths by 2020. Cancer accounts for approximately one-sixth of all deaths worldwide. In 2020, 19.3 million new cancer cases were reported, with that number expected to rise to 30.2 million by 2040. This increase in cancer incidence can be attributed to the growing geriatric population as well as the overall population.
- The increase in adoption of advanced pathology equipment
The widespread use of advanced pathology equipment such as staining systems, gross imaging, and digital microscopes is poised to significantly improve anatomic pathological practises. Digital imaging solutions outperform traditional techniques in terms of specificity and accuracy, which increases service uptake in the anatomic pathology market.
- Regulatory Compliance
Maintaining compliance with medical reforms and regulations raises the demand for these solutions.
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the anatomic pathology market.
Opportunities
In oncology drug trials, anatomic pathology products and services are used to analyse quantitative data, detect morphological structures, detect pharmacodynamics markers, and understand drug mechanisms. It also stratifies trial subjects based on tissue responses to drugs. Tissue diagnostics enable efficient trials and retrospective studies by reducing the cost and time involved in these processes.
Restraints/Challenges
The scarcity of refurbished anatomic pathology instruments is a major impediment to the market's expansion. A number of end users, primarily small and medium-sized laboratories, seek cost-effectiveness and choose refurbished systems, particularly in price-sensitive developing-country markets. Given these considerations, the demand for refurbished anatomic pathology instruments is expected to rise in the coming years, as these systems provide the same functionality as new equipment at a lower cost. This is expected to reduce revenue for companies in the market that sell branded anatomic pathology instruments.
This anatomic pathology market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anatomic pathology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Anatomic Pathology Market
The COVID-19 outbreak has had an impact on every aspect of the diagnostics industry, including the anatomic pathology market, globally. Despite the availability of emergency and out-of-hours services in hospitals, patient visits to hospitals have decreased significantly in recent months. Cancer patients have emerged as one of the pandemic's most severely affected patient groups. COVID-19 has significantly impacted the number of patients who have cancer screening, diagnosis, and treatment. The increased pressure caused by the rising rate of COVID-19 hospitalisation had resulted in the re-profiling of many hospitals and departments, including oncology clinics, for treating COVID-19 patients.
Anatomic Pathology Market Scope
The anatomic pathology market is segmented on the basis of product and services, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product & Service
- Instrument
- Consumables
On the basis of product and services, the anatomic pathology market is segmented into instrument and consumables. Instruments are further segmented into Tissue Processing Systems, Microtomes, Cryostats and Others. Consumables are further segmented into reagents, stains & dyes, fixatives, antibodies and others.
Application
- Disease Diagnosis
- Drug Discovery and Development
- Other Applications
On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery and development and other applications
End User
- Pathology Labs
- Research Institutes
- Hospitals
- Others
On the basis of end users, the anatomic pathology market is segmented into pathology labs, research institutes, hospitals and others.
Anatomic Pathology Market Regional Analysis
The anatomic pathology market is analysed and market size insights and trends are provided by country, product and services, application and end
users as referenced above.
The countries covered in the anatomic pathology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Due to the presence of major players and supportive government initiatives pertaining to training pathological programs, North America accounted for the largest revenue share. Because of favorable reimbursement policies in the United States, the increasing implementation of tissue-diagnostic related procedures in disease screening facilitates regional market growth. The Asia Pacific market is expanding due to rising demand for advanced imaging modalities, an increase in better patient care facilities, and several pathology laboratories franchising their presence. The presence of public agencies in China, such as the Pathology Branch of the Chinese Medical Association, which is aimed at assisting pathology projects, also contributes to the APAC market's rapid growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The anatomic pathology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for anatomic pathology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the anatomic pathology market. The data is available for historic period 2010-2020.
Anatomic Pathology Market Share
The anatomic pathology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anatomic pathology market.
Anatomic Pathology Market Leaders Operating in the Market Are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Eli Lilly and Company (U.S.)
- Merck & Co., Inc. (U.S.)
- Allergan (Ireland)
- AstraZeneca (U.K.)
- Johnson & Johnson Private Limited (U.S.)
- Cipla Inc. (U.S.)
- Bausch Health Companies Inc. (Canada)
- Abbott (U.S.)
Latest Developments in Anatomic Pathology Market
- Hologic received FDA premarket approval (PMA) for its ThinPrep GenesisTM processor for cytology processing and specimen transfer for downstream applications in May 2021
- PHC Holding Corporation completed the acquisition of Thermo Fisher Scientific's Anatomical Pathology business in January 2019 in order to strengthen its position in the diagnostics segment
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
